Company intelligence / Profile preview
Starpharma
Abbotsford* / Melbourne*, Victoria, Australiastarpharma.com ↗
- Ownership
- Private
- Employees
- ~50
- Development stage
- Other
01
Overview
Starpharma has commercialized several dendrimer-based products such as VivaGel BV, VivaGel Condom, and VIRALEZE Nasal Spray. Its DEP® oncology candidates have advanced through early to mid-stage clinical trials with over 350 patients treated. The company’s technology has demonstrated improved drug delivery characteristics and reduced toxicity in preclinical and clinical settings.
- Therapeutic areas
- Infectious DiseasesWomen's HealthOncology
- Modalities
- Polymer-drug conjugate therapySmall moleculeAntimicrobial agent
- Industry
- Biotech
02
Drug pipeline
13 assets12 more assets in the full pipeline.
03
Partnerships
AstraZeneca (DEP platform licensing)Medicxi/Petalion Therapeutics Limited co-founding partnershipITROM Pharmaceutical Group distribution agreement
Beyond the preview
Go deeper on Starpharma.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Starpharma.